Subscribe to RSS
DOI: 10.1055/s-2007-965787
© Georg Thieme Verlag KG Stuttgart · New York
Treatment of Postoperative Enterocutaneous Fistulas with Octreotide in Two Neonates
Publication History
received July 14, 2007
Publication Date:
26 February 2008 (online)

Abstract
Enterocutaneous fistula (EF) in newborns and prematures is a well-recognized complication after necrotizing enterocolitis and other abdominal surgical procedures. Conservative management consists of bowel rest, antibiotics, wound care, and the administration of drugs that either reduce gastrointestinal motility or secretions. Octreotide decreases gastrointestinal secretions, inhibits or blocks the effects of gastrointestinal hormones, diminishes gut motility and thus reduces the flow through the fistula. We used octreotide and were able to report successful spontaneous closure of a fistula in our 2 neonatal patients, one a premature neonate with necrotizing enterocolitis (NEC) and the other with meconium peritonitis.
Key words
octreotide - enterocutaneous fistula - neonate
References
- 1 Alvarez C, McFadden D W, Reber H A. Complicated enterocutaneous fistulas: failure of octreotide to improve healing. World J Surg. 2000; 24 533-538
- 2 Arevalo R P, Bullabh P, Krauss A N, Auld P A, Spigland N. Octreotide-induced hypoxemia and pulmonary hypertension in premature neonates. J Pediatr Surg. 2003; 38 251-253
- 3 Buyukyavuz I, Karnak I, Yigit S, Tanyel F C. Successful treatment of enterocutaneous fistula in a premature newborn by using octreotide. Turk J Pediatr. 2004; 46 289-291
- 4 Heikenen J B, Pohl J F, Werlin S L, Bucuvalas J C. Octreotide in pediatric patients. J Pediatr Gastroenterol Nutr. 2002; 35 600-609
- 5 Hesse U, Ysebaert D, de Hemptinne B. Role of somatostatin-14 and its analogues in the management of gastrointestinal fistulae: clinical data. Gut. 2001; 49 (Suppl 4) iv11-iv21
- 6 Hollington P, Mawdsley J, Lim W, Gabe S M, Forbes A, Windsor A J. An 11-year experience of enterocutaneous fistula. Br J Surg. 2004; 91 1646-1651
- 7 Nubiola P, Badia J M, Martinez-Rodenas F, Gil M J, Segura M, Sancho J, Sitges-Serra A. Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201-995. Ann Surg. 1989; 210 56-58
- 8 Sancho J J, di Costanzo J, Nubiola P, Larrad A, Beguiristain A, Roqueta F, Franch G, Oliva A, Gubern J M, Sitges-Serra A. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula. Br J Surg. 1995; 82 638-641
M.D. Ramazan Karabulut
Gezegen Sokak 1/10 GOP
06670 Çankaya-Ankara
Turkey
Email: karabulutr@yahoo.com